COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,886 Articles (22,568 medRxiv, 8,318 bioRxiv)

Most recent first Previous |  Page 2805: Articles 28041-28050  | Next

Bacteremia and Blood Culture Utilization During COVID-19 Surge in New York City
Sepulveda, J., Westblade, L. F., Whittier, S., Satlin, M. J., Greendyke, W., Aaron, J. G., Zucker, J. E., Dietz, D., Sobieszczyk, M. E., Choi, J. J., Liu, D., Espinal, K., Russell, S., Camp, D., Connelly, C., Green, D. A.
10.1101/2020.05.05.20080044 — Posted: 2020-05-06
Psychophysical Olfactory Findings of Mild-to-moderate COVID-19 Patients: Preliminary Report.
Lechien, J. R., saussez, s., Cabaraux, P., Hans, S., Khalife, M., Martiny, D., Chiesa, C.
10.1101/2020.05.02.20070581 — Posted: 2020-05-06
Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention
Wyler, E., Mösbauer, K., Franke, V., Diag, A., Gottula, L. T., Arsie, R., Klironomos, F., Koppstein, D., Ayoub, S., Buccitelli, C., Richter, A., Legnini, I., Ivanov, A., Mari, T., Del Giudice, S., Papies, J. P., Müller, M. A., Niemeyer, D., Selbach, M., Akalin, A., Rajewsky, N., Drosten, C., Landthaler, M.
10.1101/2020.05.05.079194 — Posted: 2020-05-05 Discussion: Onsite
Group Testing Performance Evaluation for SARS-CoV-2 Massive Scale Screening and Testing
Nalbantoglu, O. U.
10.1101/2020.05.02.20080390 — Posted: 2020-05-05
Identification of Candidate COVID-19 Therapeutics using hPSC-derived Lung Organoids
Han, Y., Yang, L., Duan, X., Duan, F., Nilsson-Payant, B. E., Yaron, T. M., Wang, P., Tang, X., Zhang, T., Zhao, Z., Bram, Y., Redmond, D., Houghton, S., Nguyen, D., Xu, D., Wang, X., Uhl, S., Huang, Y., Johnson, J. L., Xiang, J., Wang, H., Pan, F. C., Cantley, L. C., tenOever, B. R., Ho, D. D., Evans, T., Schwartz, R. E., Chen, H. J., Chen, S.
10.1101/2020.05.05.079095 — Posted: 2020-05-05
COVID-19, smoking, and inequalities: a cross-sectional survey of adults in the UK
Jackson, S. E., Brown, J., Shahab, L., Steptoe, A., Fancourt, D.
10.1101/2020.04.30.20086074 — Posted: 2020-05-05
SARS-CoV-2 Spike Glycoprotein Receptor Binding Domain is Subject to Negative Selection with Predicted Positive Selection Mutations
Li, Y., Wang, Y., Qiu, Y., Gong, Z., Deng, L., Pan, M., Yang, H., Xu, J., Yang, L., Li, J.
10.1101/2020.05.04.077842 — Posted: 2020-05-05
Global Spread of SARS-CoV-2 Subtype with Spike Protein Mutation D614G is Shaped by Human Genomic Variations that Regulate Expression of TMPRSS2 and MX1 Genes
Bhattacharyya, C., Das, C., Ghosh, A., Singh, A. K., Mukherjee, S., Majumder, P. P., Basu, A., Biswas, N. K.
10.1101/2020.05.04.075911 — Posted: 2020-05-05
Selectomic and Evolvability Analyses of the Highly Pathogenic Betacoronaviruses SARS-CoV-2, SARS-CoV, and MERS-CoV
May, M., Rostama, B., Relich, R. F.
10.1101/2020.05.05.078956 — Posted: 2020-05-05
Translation-associated mutational U-pressure in the first ORF of SARS-CoV-2 and other coronaviruses
Khrustalev, V. V., Giri, R., Khrustaleva, T. A., Kapuganti, S. K., Stojarov, A. N., Poboinev, V. V.
10.1101/2020.05.05.078238 — Posted: 2020-05-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).